TickerFactsScreenerDevelopers

Ultragenyx Pharmaceutical Inc. (RARE) — Operating Income

Annual figures by fiscal year, from SEC filings.

2012: -$15.98M2013: -$32.28M2014: -$56.78M2015: -$147.74M2016: -$248.01M2017: -$328.94M2018: -$371.37M2019: -$424.17M2020: -$330.12M2021: -$381.74M2022: -$648.92M2023: -$569.00M2024: -$536.00M2025: -$535.00M-$535.00M
2012Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$535.00M+0.2%
2024-$536.00M+5.8%
2023-$569.00M+12.3%
2022-$648.92M-70.0%
2021-$381.74M-15.6%
2020-$330.12M+22.2%
2019-$424.17M-14.2%
2018-$371.37M-12.9%
2017-$328.94M-32.6%
2016-$248.01M-67.9%
2015-$147.74M-160.2%
2014-$56.78M-75.9%
2013-$32.28M-101.9%
2012-$15.98M—